Peter Johann, Chief Executive Officer of Lumendi, noted, “Our products are designed to provide an edge in tackling the complexities of polypectomies, thereby improving patient outcomes and delivering higher curative rates. That said, the positive customer response to the DiLumen EZ is a testament to our commitment, and our ability to deliver transformative solutions for challenging gastrointestinal interventions.”